ARTICLE | Clinical News
CC-115: Phase I data
June 13, 2016 7:00 AM UTC
Top-line data from 82 evaluable patients with relapsed or refractory advanced solid tumors and hematological malignancies in a 2-part, open-label, international Phase Ia/Ib trial showed that oral CC-1...